The Safety of Medicinal Plants Used in the Treatment of Vitiligo and Hypermelanosis: A Systematic Review of Use and Reports of Harm

References

• Khandalavala BN, Nirmalraj MC. Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet. Clin Dermatol. 2014;6(3):283–287.
   Google Scholar
• Torok HM. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream. Am J Clin Dermatol. 2006;7:223–230. doi:10.2165/00128071-200607040-00003
   PubMed Web of Science ®Google Scholar
• Khushboo PS, Jadhav VM, Kadam VJ, et al. Psoralea corylifolia linn. – “kushtanashini”. Pharmacogn Rev. 2010;4(7):69–76. doi:10.4103/0973-7847.65331
   PubMedGoogle Scholar
• Szczurko O, Born HS. A systematic review of natural health product treatment for vitiligo. BMC Dermatol. 2008;8:2. doi:10.1186/1471-5945-8-2
   Google Scholar
• Fisk WA, Agbai O, Lev-Tov HA, Sivamani RK. The use of botanically derived agents for hyperpigmentation: a systematic review. J Am Acad Dermatol. 2014;70(2):352–365. doi:10.1016/j.jaad.2013.09.048
   Web of Science ®Google Scholar
• Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2013;4:177.
   Web of Science ®Google Scholar
• Masoumeh G, Ali E. Clinical efficacy of liposome-encapsulated Aloe vera on melasma treatment during pregnancy. J Cosmet Laser Ther. 2017;19(3):181–187. doi:10.1080/14764172.2017.1279329
   Web of Science ®Google Scholar
• Shahla K, Ali A, Hossein M, et al. The efficacy of topical use of petroselinum crispum (parsley) versus hydroquinone cream for reduction of epidermal melasma: a randomized clinical trial. AJP. 2015;5(1):124–125.
   Google Scholar
• Debbie M, Palmer DO, Jennifer SK. A double blind, randomized, controlled clinical trial evaluating the efficacy and tolerance of a novel phenolic antioxidant skin care system containing Coffea arabica and concentrated fruit and vegetable extracts. J Drugs Dermatol. 2010;9(12):1480–1487.
   Web of Science ®Google Scholar
• Buggiani G, Tsampau D, Hercogovà J, et al. Clinical efficacy of a novel topical formulation for vitiligo: compared evaluation of different treatment modalities in 149 patients. Dermatol Ther. 2012;25(5):472–476. doi:10.1111/j.1529-8019.2012.01484.x
   Web of Science ®Google Scholar
• Hussain I, Hussain I, Manan A, et al. Fabrication of anti-vitiligo ointment containing Psoralea corylifolia: in vitro and in vivo characterization. Drug Des Devel Ther. 2016;10:3805–3816. doi:10.2147/DDDT.S114328
   PubMed Web of Science ®Google Scholar
• Orest S, Neill S, Anna T, et al. Ginkgo Biloba for the treatment of vitiligo Vulgaris: an open label pilot clinical trial. BMC Complement Altern Med. 2011;21:1–9.
   Google Scholar
• Ahmed R, Abu R, Noor MA, et al. Evaluation of standardized extract of Ginkgo Biloba in vitiligo remedy. Asian J Pharm Clin Res. 2013;6(5):127–130.
   Google Scholar
• Parasad P. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol. 2003;28:285–287. doi:10.1046/j.1365-2230.2003.01207.x
   Web of Science ®Google Scholar
• Jun Y, Atsushi S, Shoichi T, et al. Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma. Phytother Res. 2004;18:895–899. doi:10.1002/ptr.1537
   Web of Science ®Google Scholar
• Beidi KL, Usha Z, Chopra CL. Picrorhiza kurroa, an ayurvedic herb, may potentiate photochemotherapy in vitiligo. J Ethnopharmacol. 1989;27:347–352. doi:10.1016/0378-8741(89)90009-3
   Web of Science ®Google Scholar
• Glen A, Nino C, Ailynne V, et al. Maria Jasmin Jamora MD. A comparative study of the safety and efficacy of 75% Mulberry (Morus alba) Extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled Trial. J Drugs Dermatol. 2011;10(9):1025–1031.
   Web of Science ®Google Scholar
• Ammar M, Ahmed M, Isha L, et al. randomized, double-blinded, placebo controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma. JAMA Dermatol. 2013;149(8):981–983. doi:10.1001/jamadermatol.2013.4294
   Web of Science ®Google Scholar
• Lucy K, Martin M. A randomized double-blind placebo controlled study evaluating the effectiveness and tolerability of oral polypodium leucotomos in patients wit melasma. J Am Acad Dermatol. 2012;Ab21:4630.
   Google Scholar
• Eduardo R, Pedro J, Elena H, et al. Systemic Immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study. J Dermatol Sci. 2006;41:213–216. doi:10.1016/j.jdermsci.2005.12.006
   Web of Science ®Google Scholar
• Martiza A, Middelkamp H, Madhu A, et al. Orally administered Polypodium leucotomos extract decreases psoralen UVA induced phototoxicity, pigmentation, and damage of human skin. J Am Acad Dermatol. 2004;50:41–49. doi:10.1016/S0190-9622(03)02732-4
   Web of Science ®Google Scholar
• Mark S, Nestor BD, Nicole S. Safety and efficacy of oral Polypodium leucotomos extract in healthy adult subjects. J Clin Aesthet Dermatol. 2015;8(2):19–23.
   Google Scholar
• Colucci R, Dragoni F, Conti R. Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E, and carotenoids in vitiligo treatment. Dermatolog Treat. 2015;28:17–21. doi:10.1111/dth.12172
   Web of Science ®Google Scholar
• Adilson C, Tatiana C, Juliana M. Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma. An Bras Dermatol. 2010;85(5):613–620. doi:10.1590/S0365-05962010000500003
   Web of Science ®Google Scholar
• Ni Z, Mu Y, Gulati O. Treatment of melasma with pycnogenol. Phytother Res. 2002;16:567–571. doi:10.1002/ptr.1085
   PubMed Web of Science ®Google Scholar
• Mendoza CG. A randomized, double blind, placebo-controlled clinical trial on the efficacy of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos. Int J Dermatol. 2014;53:1412–1416. doi:10.1111/ijd.12690
   Web of Science ®Google Scholar
• Morag M, Nawrot J, Siatkowski I, et al. A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β -arbutin, in selected skin hyperpigmentations. J Cosmet Dermatol. 2015;14(3):185–190. doi:10.1111/jocd.12147
   PubMed Web of Science ®Google Scholar
• Leeuw JD, Assen YJ, Van N, et al. Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation. J Eur Acad Dermatol Venereol. 2011;25(1):74–81. doi:10.1111/j.1468-3083.2010.03701.x
   Web of Science ®Google Scholar
• Saraceno R, Steven P. Nistico, monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study. Dermatolog Treat. 2009;25:391–394. doi:10.1111/j.1529-8019.2009.01252.x
   Web of Science ®Google Scholar
• Valkova TC. Treatment of vitiligo with local Khellin and UVA: comparison with systemic PUVA. Clin Exp Dermatol. 2003;29:180–184. doi:10.1111/j.1365-2230.2004.01462.x
   Web of Science ®Google Scholar
• Orecchia G, Sangalli M, Gazzaniga A, Giordano F. Topical photochemotherapy of vitiligo with a new Khellin formulation. J Dermatolog Treat. 1998;9(2):65–69. doi:10.3109/09546639809161375
   Web of Science ®Google Scholar
• Procaccini E, Riccio G, Monfrecola G. Ineffectiveness of topical Khellin in photochemotherapy of vitiligo. J Dermatolog Treat. 1995;6(2):117–120. doi:10.3109/09546639509097164
   Web of Science ®Google Scholar
• Bernhard O, Adrian T, Herbert H. Treatment of vitiligo with Khellin and Ultraviolet A. J Am Acad Dermatol. 1988;18:693–701. doi:10.1016/S0190-9622(88)70092-4
   Web of Science ®Google Scholar
• Mofty M, Bosseila M, Mashaly HM, et al. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial. Clin Exp Dermatol. 2013;38(8):830–835. doi:10.1111/ced.12099
   Web of Science ®Google Scholar
• Shivani B, Bijaylaxmi S, Vijay G. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone. Photodermatol Photoimmunol Photomed. 2013;29:311–317. doi:10.1111/phpp.12072
   Web of Science ®Google Scholar
• Ranjeeta S, Sudha A, Tapan K. Systemic PUVA vs narrowband UVB in the treatment of Vitiligo: a randomized controlled Study. Int J Dermatol. 2012;51:1107–1115. doi:10.1111/j.1365-4632.2011.05454.x
   Web of Science ®Google Scholar
• Yones SS, Palmer RA, Garibaldinos TM, Hawk JL. Randomized double-blind trial of treatment of Vitiligo: efficacy of psoralen–UV-A therapy vs narrowband–UV-B therapy. Arch Dermatol. 2007;143:578–584. doi:10.1001/archderm.143.5.578
   PubMedGoogle Scholar
• Bhatnagar A, Kanwar AJ, Parsad D, De D. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. J Eur Acad Dermatol Venereol. 2007;21(10):1381–1385. doi:10.1111/j.1468-3083.2007.02283.x
   Web of Science ®Google Scholar
• Ermis A. Is the efficacy of Psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol. 2001;145:472–475. doi:10.1046/j.1365-2133.2001.04286.x
   PubMed Web of Science ®Google Scholar
• Ameen E, Chu A. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol. 2001;145:476–479. doi:10.1046/j.1365-2133.2001.04381.x
   PubMed Web of Science ®Google Scholar
• Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in Vitiligo. Dermatology. 1998;197(2):167–170. doi:10.1159/000017991
   PubMed Web of Science ®Google Scholar
• Parasad D, Roma P, Sunil D, et al. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol. 2004;50(1):63–67. doi:10.1016/S0190-9622(03)00786-2
   Web of Science ®Google Scholar
• Wiete W, Ludmila N. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol. 1997;133:1525–1528. doi:10.1001/archderm.1997.03890480045006
   Google Scholar
• Mofty A, Hussein E. Clinical study of a new preparation of 8-methoxypsoralen in photochemotherapy. Int J Dermatol. 1994;33(8):588–593. doi:10.1111/j.1365-4362.1994.tb02904.x
   Web of Science ®Google Scholar
• Africk J, Fulton J. Treatment of vitiligo with topical trimethylpsoralen and sunlight. Br J Dermatol. 1989;84:151–156. doi:10.1111/j.1365-2133.1971.tb06858.x
   Web of Science ®Google Scholar
• Sehgal. A comparative clinical evaluation of trimethylpsoralen, psoralen and 8-methoxypsoralen in treating vitiligo. Int J Dermatol. 1975;14:205–208. doi:10.1111/ijd.1975.14.3.205
   PubMedGoogle Scholar
• Mofty AME, Nada MM. On the treatment of vitiligo. Int J Dermatol. 1971;10(4):262–266. doi:10.1111/j.1365-4362.1971.tb01709.x
   Google Scholar
• Dushet P, Schwarz T, Pusch M, Gshnait F. Marked increase of liver transaminases after khellin and UVA therapy. J Am Acad Dermatol. 1989;21(3):592–593. doi:10.1016/S0190-9622(89)80248-8
   Web of Science ®Google Scholar
• Kreuter A, Gambichier AA, Jansen T. Localized vitiligo successfully treated with cream-psoralen + Ultraviolet A. J Eur Acad Dermatol Venereol. 2001;15:357–358.
   Web of Science ®Google Scholar
• Maurice CJ. The dangers of herbalism. BMJ. 1989;299:1204. doi:10.1136/bmj.299.6709.1204
   Web of Science ®Google Scholar
• David W, Mai CO. Childhood vitiligo successfully treated with Bath PUVA. Pediatr Dermatol. 1998;15(1):53–55. doi:10.1046/j.1525-1470.1998.1998015053.x
   Web of Science ®Google Scholar
• Zouhir D. Successful treatment of facial vitiligo with honey bee, Allium cepa and Avena sativa combined to sun light exposure: a case clinical trial. Int J Pharm Clin Res. 2015;7(1):9–14.
   Google Scholar
• Rigmor M, Jette H. Methoxsalen and multiple basal cell carcinomas. Arch Dermatol. 1976;112:1613–1614. doi:10.1001/archderm.1976.01630350079027
   Google Scholar
• Deborah AS, Stwart M. A rare case of acute hepatitis induced bu use of Babchi seeds as an ayurvedic remedy for vitiligo. BMJ Case Rep. 2014;1–3. doi:10.1136/bcr-2013-200958
   Google Scholar
• Abdel N, Okby WM. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin. Clinical Dermatol. 2004;29:380–382.
   Google Scholar
• World Health Organization.TM.VigiAccess Available from: www.vigiaccess.org. Accessed December 9, 2017.
   Google Scholar
• Donata SR, Kesavan M, Austin KS, Rajagopalan K, Kuttan R. Clinical trial of certain ayurvedic medicines indicated in vitiligo. Anc Sci Life. 1990;9:202–206.
   Google Scholar
• Psoralea corylifolia. Available from: http://examine.com/supplements/Psoralea+Corylifolia/summary2-1. Accessed 22 Jul 2013.
   Google Scholar
• New WB. Manual of Homeopathic Materia Medica and Repertory. 9th ed. New Delhi: B. Jain Publishers Pvt. Ltd; 2002:11–29.
   Google Scholar
• Stephen B, Harley G, Amy P, et al. Spontaneous bleeding associated with Ginkgo biloba. A case report and systematic review of the literature. J Gen Intern Med. 2005;20:657–661. doi:10.1007/s11606-005-0114-4
   Web of Science ®Google Scholar
• Ansari R, Aswal B, Chander R, et al. Hepatoprotective activity of kutin- the iridoid glycoside mixture of Picrorhiza Kurroa. Indian J Med Res. 1988;87:401–404.
   PubMed Web of Science ®Google Scholar
• Handa S, Sharma A, Chakraborty K. Natural products and plants as liver protecting drugs. Fitoterapia. 1986;58:307–351.
   Google Scholar
• Middelkamp-Hup MA, Pathak MA, Parrado C, et al. Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. J Am Acad Dermatol. 2004;51:910–918. doi:10.1016/j.jaad.2004.06.027
   PubMed Web of Science ®Google Scholar
• Gonzales S, Pathak MA, Cuevas J, Villarrubia VG, Fitzpatrick TB. Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and-psoralen induced phototoxic reactions as well as depletion of Langerhans cells in human skin. Photodermatol Photoimmunol Photomed. 1997;13:50–60. doi:10.1111/j.1600-0781.1997.tb00108.x
   PubMed Web of Science ®Google Scholar
• Anrep GV, Kenawy MR, Barsoum GS. The coronary vasodilator action of khellin. Am Heart J. 1949;37:531–542. doi:10.1016/0002-8703(49)91131-X
   PubMed Web of Science ®Google Scholar
• Herbert Hbnigsmann MD, Bernhard Ortel MD, Tanew A. Reply. J Am Acad Dermatol. 1989;21(3):593–594. doi:10.1016/S0190-9622(89)80249-X
   Web of Science ®Google Scholar
• Armbrust CA, Levine SA. The treatment of angina pectoris with a preparation of khelIin. Am J Med Sci. 1950;220:127. doi:10.1097/00000441-195008000-00002
   Web of Science ®Google Scholar
• Hofer A, Karl H, Wolf P. Long-term results in the treatment of vitiligo with oral khellin plus UVA. Eur J Dermatol. 2001;11:225–229.
   PubMed Web of Science ®Google Scholar
• Morliere P, Honigsmann H, Averbeck D. Phototherapeutic, photobiologic and photosensitizing properties of Khellin. J Invest Dermatol. 1988;90:720–724. doi:10.1111/1523-1747.ep13083852
   PubMed Web of Science ®Google Scholar
• Ortonne J. Psoralen therapy in vitiligo. Clin Dermatol. 1989;7(2):120–135. doi:10.1016/0738-081X(89)90062-X
   PubMed Web of Science ®Google Scholar
• Said HM. Hamdard pharmacographica. Indica. 1972;XV(Special Issue):412–413.
   Google Scholar
• Leroy D, Dompmartin A, Dubreuil A, et al. Cryotherapy of PUVA lentigines. Br J Dermatol. 1996;135:988–990. doi:10.1046/j.1365-2133.1996.d01-1108.x
   Web of Science ®Google Scholar
• Collins P, Rogers S. Bath water compared with oral delivery of 8-methoxypsoralen PUVA for chronic plaque type psoriasis. Br J Dermatol. 1992;127:392–395. doi:10.1111/j.1365-2133.1992.tb00460.x
   PubMed Web of Science ®Google Scholar
• Ortel B, Perl S, Kinaciyan T, et al. Comparison of narrow-band (311 nm). UVB and broad band UVA after oral or bath water 8-methoxypsoralen in the treatment of Psoriasis. J Am Acad Dermatol. 1993;29:736–740. doi:10.1016/0190-9622(93)70239-P
   PubMed Web of Science ®Google Scholar
• Forton F, Germaux MA, Brasseur T, et al. Demodicosis and rosacea: epidemiology and significance in daily dermatologic practice. J Am Acad Dermatol. 2005;52:74–87. doi:10.1016/j.jaad.2004.05.034
   PubMed Web of Science ®Google Scholar
• mutalik SD, Pethe SV, Nikam BP, et al. Facial frictional melanosis in Indian patients: defining the entity. Clin Dermatol Rev. 2019;3(1):78–83. doi:10.4103/CDR.CDR_6_18
   Google Scholar
• Shekhaar N, Radhakrishnan PK. Demodex induced facial frictional melanoses. Aust J Dermatol. 2020;61(4):e490–e492.
   Web of Science ®Google Scholar
• Tian Y, Li CP, Deng Y. Anti-mite activity and skin safety of Herbal taraxaci extract for Demodex folliculorum. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2007;25(2):133–136.
   Google Scholar
• Tian Y, Li CP. Anti-mite activities of 25 kinds of traditional Chinese medicines for Demodex folliculorum]. Zhong Yao Cai. 2006;10:1013–1015.
   Google Scholar
• Faas L, Venkatasamy R, Hider RC, Young AR, Soumyanath A. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model. Br J Dermatol. 2008;158:941–950. doi:10.1111/j.1365-2133.2008.08464.x
   PubMed Web of Science ®Google Scholar
• Mihăilă B, Dinică RM, Tatu A, et al. New insights in vitiligo treatments using bioactive compounds from Piper nigrum. Exp Ther Med. 2019;17(2):1039–1044. doi:10.3892/etm.2018.6977
   PubMed Web of Science ®Google Scholar